Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Aesthetic Plastic Surgery|June 27, 2019
A Review of National Insurance Coverage of Post-bariatric Upper Body LiftLedibabari M Ngaage, John Rose, Lauren Pace, et al.
Surgical Endoscopy|February 24, 2016
Red cell distribution width is a novel biomarker that predicts excess body-mass index loss 1 year after laparoscopic Roux-en-Y gastric bypassEric S Wise, Kyle M Hocking, Adam Weltz, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 17, 2023
Monitoring performance in laparoscopic gastric bypass surgery using risk-adjusted cumulative sum at 2 high-volume centersKyle W Blackburn, Florence E Turrentine, Bruce D Schirmer, et al.
Pacing and Clinical Electrophysiology : PACE|August 8, 2008
New-onset orthostatic intolerance following bariatric surgerySreedhar R Billakanty, Mark D Kligman, Yousuf M Kanjwal, et al.
Plastic and Reconstructive Surgery|January 28, 2020
Review of Insurance Coverage for Abdominal Contouring Procedures in the Postbariatric PopulationLedibabari M Ngaage, Adekunle Elegbede, Lauren Pace, et al.
Obesity Surgery|October 23, 2021
Insurance Coverage of Pediatric Bariatric Surgery: a Cross-Sectional Analysis of the USABrooks J Knighton, Cynthia T Yusuf, Michael Ha, et al.
Annals of Plastic Surgery|January 7, 2020
A Cross-sectional Analysis of Insurance Coverage of Extremity Contouring After Massive Weight LossLedibabari M Ngaage, Philip J Wasicek, Joseph Puthumana, et al.
Obesity Surgery|November 22, 2019
Insurance Coverage Criteria for Bariatric Surgery: A Survey of PoliciesSelim G Gebran, Brooks Knighton, Ledibabari M Ngaage, et al.
Quintessence International (Berlin, Germany : 1985)|September 4, 2024
Diagnostic approach used by US general dental practitioners following discovery of oral lesions suspicious for malignancy/premalignancy: findings from the National Dental Practice-Based Research NetworkWalter J Psoter, Alexander Ross Kerr, Scott L Tomar, et al.
British Journal of Clinical Pharmacology|July 27, 2005
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693J P van der Post, S J de Visser, M L de Kam, et al.
Pageof 7